My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


OpenAI, Anthropic, SpaceX IPOs Could End Big...
Adobe Pauses Price Hikes For 'Short-Term' AI...
Trump Says Iran 'Better Get Their Act Togethe...
GameStop Didn't Make Money With Its Bitcoin B...
Value Investors Question SpaceX's Record IPO:...
Google Sounds Alarm On Active Oracle PeopleSo...
Chinese Customers Can Now Order NVIDIA's Vera...
SpaceX's IPO Could Spark A Venture Capital Fr...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    HIMS & HERS HEALTH INC (NYSE: HIMS)

    Overview
    current price
    $26.82
    $26.82
    change
    -2.05 | -7.10%
    -2.05 | -7.10%
    Yesterday's Close
    28.87
    open
    28.68
    volume
    19.05 M
    30d. avg volume.
    21.44 M
    1 day
    26.52 - 28.78
    52 weeks
    13.74 - 70.43
    p/e
    0.00
    beta
    2.3731
    market cap
    5.98 B
    dividend yield
    0.00%
    Industry
    -
    hims by TradingView
    News and Commentary
    Novo Nordisk CEO Sees Opportunity For 15 Million New Patients As Medicare Covers Obesity Drugs Novo Nordisk (NVO
    Novo Nordisk Takes Legal Action Against Hims & Hers Over Wegovy Knock Offs Novo Nordisk A/S (NVO
    Hims & Hers Super Bowl Ad For Cancer Test Raises Questions Over Reliability The Super Bowl ad by Hims & Hers (
    Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans Super Bowl LX aired on Sunday, Feb. 8, 2026, and the Seattle Seahawks defeated the New England Patriots 29-13, in a game that saw 30 of the 42 total points scored in the fourth q...
    Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.
    Novo Nordisk Implodes After Wegovy Warning—Is The Weight-Loss Bubble Bursting? Novo Nordisk A/S (NVO&n...
    Bank Of America Loves These 8 Stocks For Third Quarter—And Says To Dump These 2 Fast Bank of America dropped its top 10 stock ideas for the third quarter of 2025, and the list includes some familiar names like Boeing Co.
    Hims & Hers Navigates Novo Nordisk Breakup And Compounding Lawsuits Hims & Hers Health, Inc. (HIM...
    Market Update: Dow Jumps 300 Points Following Muted Iran Response to U.S. Weekend Attack Stocks were volatile on Monday, but ultimately climbed higher after the United States joined Israel's war against Iran over the weekend, striking three nuclear sites on Saturday....
    Hims & Hers: The Next Amazon? Novo Nordisk Might Be Prime Delivery Hims & Hers Health Inc. (HIMS...
    StockTwits
    StockTwits
    Most Shared
    Starbucks Stock Holds Steady As Investors Digest Extensive Corporate Restructuring Plan
    IBM Is Chasing A '$1 Trillion Value Creation Engine' — And It's Spending $15 Billion To Get There
    Consumers Are Feeling The Squeeze — And That Could Be Walmart's Biggest Advantage
    Most Popular
    Meta's $125 Billion AI Bet Might Be The Capex Trap Of The Decade
    Starbucks Stock Holds Steady As Investors Digest Extensive Corporate Restructuring Plan
    AI's Memory Shortage Runs Into 2028 — Goldman Stays Bullish On SanDisk, Samsung, SK Hynix
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Tesla
    Coronavirus Impact
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?